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researchers in Health and Environment Research participat-
ing in ARI surveillance.
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Redesignation of Enterovirus 71 Genotypes
Y.F. Chan ∗, S. AbuBakar
University Malaya, Kuala Lumpur, Malaysia
Background: The average sequence divergence between
each enterovirus 71 (EV-71) subgenotype has been previ-
ously established using VP1 gene sequences. However, VP1
only encompasses 12% of the complete genome and other
non-structural genomic regions are also phylogenetically
informative. In the present study, using the complete EV-71
genome sequences, pairwise sequence comparisons (PASC)
were analyzed to standardize the genotyping of EV-71.
Methods: With the recent availability of 41 complete EV-
71 genomes of various subgenotypes and 12 complete human
enterovirus A(HEV-A) genomes, genome sequence similari-
ties were visualized by plotting the frequency distribution
of the pairwise identity percentages.
Results: Using the complete genome, the average
sequence divergences between HEV-A and EV-71 were
26.15% (22—28%) at the nucleotide level and 15.01% (9—21%)
at the amino acid level. The average nucleotide sequence
divergence between EV-71 genotypes (A, B and C) was
19.64% (17—21%), while between and within the subgeno-
types (B2-B5 and C1-C4) were 10.75% (6—14%) and 3.09%
(1—5%) respectively. Based on these results, subgenotype
C4 which has nucleotide sequence divergence of 18.13%
(17—20%) when compared with other subgenotypes C (C1-
C3) exceeded the cutoff divergence value assigned for EV-71
subgenotyping, and should be redesignated as a new geno-
type D. On the other hand, subgenotype B5 which has only
average nucleotide sequence divergence of 5.56% (4—7%)
when compared with other subgenotypes B4 did not justify
its designation as a new subgenotype.
Conclusion: The average divergence values generated
through PASC between members of the EV-71 and HEV-A can
systematically delineate the HEV-A serotypes, EV-71 geno-
types and subgenotypes.
doi:10.1016/j.ijid.2008.05.811
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HPV and Cervical Cancer: Screening of Young Women for
the Presence of Human Papillomavirus Infection
P. Datta ∗, R.K. Patro, N. Bhatla, N. Singh
All India Institute of Medical Sciences, Delhi, India
Background: Human Papillomavirus is universally
accepted as a necessary cause for invasive cervical carci-
noma. The incidence of cervical cancer is 510,000 cases
worldwide of which 132,000 cases occur in India with high
mortality rate. The causal role of human papilloma virus in
all cancers of the uterine cervix has been established. HPV
infection is overwhelming the most important predictor
of increased risk for cervical cancer and its premalignant
lesions. There is limited data available for HPV prevalence
in younger population.
Aim: To analyze the prevalence of HPV infection in young
women (16—24 years). Methodology: 1000 samples of exfo-
liated cervical cells collected (in DIGENE STM) from women
aged 16—24 years, resident of an urban slum area in Delhi
were tested. The samples were processed for Hybrid Cap-
ture (HC2) using DIGENE HC2 assay. HPV DNA was detected
by PCR using PGMY consensus primers. HPV genotyping was
done for HPV positive samples using the Reverse Line blot
array.
Results: 84/1000 (8.4%) samples were positive for HPV.
30/84 (35.7%) samples were HPV 16 positive and 5/84 (6%)
sample was positive for HPV 18. Mixed HPV infections were
found in 34 samples.
Conclusions: The prevalence of HPV in the above popu-
lation was found to be 8.4%. HPV 16 was the most common
type detected. This study for HPV prevalence and type can
give an indication of the natural history of HPV infection
in the younger age group in whom the HPV infection rate
is known to be the highest. Prevalence in younger popula-
tion in our region will give an estimation of patterns of HPV
infection and enable to identify the target population for
vaccination.
doi:10.1016/j.ijid.2008.05.812
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An Evaluation of the Epidemiology of Adenovirus Infec-
tions in Kenya Using a Sustained Laboratory-Based
Sentinel Surveillance System
R. Achilla ∗, W. Bulimo, D. Schnabel
US Army Medical Research Unit - Kenya, Nairobi, Kenya
Background: The burden of adenovirus as a respira-
tory disease etiology in sub-Saharan Africa has not been
well studied. In the developed world it is a signiﬁcant
cause of childhood respiratory disease throughout the year.
Our laboratory coexisting with Kenya’s National Inﬂuenza
Center (NIC) - developed the ﬁrst sustained, comprehen-
sive sentinel surveillance system for viral upper respiratory
infections in Kenya. This effort began in July 2006 as a sub-
activity of the Kenyan National Inﬂuenza Network. In total,
fourteen different respiratory viruses are under surveillance
including adenovirus.
Method: Eight public hospitals distributed across and
representing the entire country comprise our collection
site network. Nasopharyngeal swab specimens are col-
lected within 72 hours of symptom onset from consenting
patients presenting with inﬂuenza like illness. Specimens
are transported in liquid nitrogen to the NIC where they are
inoculated in the Hep2 cell line and incubated. Immunoﬂu-
orescence assays are carried out using group speciﬁc
antibodies for adenoviruses on all cultures showing cyto-
pathic effect
Results: Out of 360 viruses isolated from patient sam-
ples in the initial one-and-half years of the surveillance, 120
isolates (33.3%) were adenovirus. 60% of these cases were
male, and all were children under ﬁve years. 71% originated
in western Kenya. Adenovirus infection occurred throughout
the year.
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Conclusion: These initial results indicate that aden-
oviruses are a signiﬁcant cause of respiratory disease among
children under ﬁve. Specimen collection is on-going, and
future results will further clarify the epidemiology of ade-
novirus disease in Kenya. Subtyping of the isolates will be
determined by PCR and reported.
doi:10.1016/j.ijid.2008.05.813
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Development of Novel Photo-inactivation Nanotechnology
against Dengue Virus
Y.L. Lee1,∗, D.K. Chatterjee2, Y. Zhang2, M.L. Ng1, J.J.H.
Chu1
1 Department of Microbiology, Yong Soo Lin School of
Medicine, National University of Singapore, Block MD4, 5
Science Drive 2, Singapore, Singapore
2 Division of Bioengineering, Faculty of Engineering,
National University of Singapore, Singapore, Singapore
Background: Photodynamic therapy utilizes a photosen-
sitizer, which upon excitation, emits energy that could be
transduced by surrounding molecular oxygen to produce rad-
ical oxygen species. Interaction between the singlet oxygen
species and viruses may have a virucidal effect. In this study,
the potential of using a novel photodynamic system to inac-
tivate enveloped virus was investigated.
Methods: The photosensitizer used was zinc-
phthalocyanine (ZnPC), which was absorbed onto a
novel two-photon nanotransducer (NaYF4) that is activated
by near infrared light (NIR). Dengue 2 virus was mixed with
different concentrations of nanoparticles and exposed to
a NIR light source at varying distances (5 cm and 10 cm)
and durations (5minutes and 10minutes). The amount
of surviving viruses was analyzed using plaque assay and
compared with untreated virus samples. Further photo-
inactivation study is being done on dengue 2 virus-infected
HepG2 cells using nanoparticles that were conjugated with
antibodies speciﬁc for the dengue virus envelope protein.
The infected cells were incubated with the antibody-
conjugated nanoparticles (4 to 110g/mL) and subjected
to NIR illumination (10 cm for 5minutes).
Results: The level of virus inactivation increased with
higher nanoparticle concentrations and at shorter distance
and longer illumination from the NIR source. At all con-
ditions, virus inactivation was complete when 2.2mg/mL
nanoparticles were used and at 44g/mL, virus titer was
reduced by more than 50%. Conjugation with antibody may
enhance the localization of the photo-inactivation site to
targeted viruses or to virus-infected cells only, as shown
by electron and laser scanning confocal microscopy. In
addition, cell viability (MTT) assay showed that the photo-
bleaching effect by NIR light on HepG2 cells was only
minimal.
Conclusion: Given its effectiveness in eradicating virus
activity and its non-cytotoxic effect on cells, photodynamic
therapy using NIR light could be a feasible novel technology
with important implications in treating virus-infected blood
or cellular samples.
doi:10.1016/j.ijid.2008.05.814
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Susceptibility to Oseltamivir and Amantadine of Human
Inﬂuenza Viruses Circulating in Portugal
V. Correia ∗, H. Rebelo-de-Andrade, L. Santos, M. Gíria
Centro Nacional da Gripe, Instituto Nacional de Saúde
(Research grant supported by Calouste Gulbenkian Founda-
tion - Portugal), Lisboa, Portugal
Background: Since 2002, increasing incidence of aman-
tadine resistance has been detected worldwide. In a minor
extent, emergence of oseltamivir-resistant strains has been
identiﬁed during 2007/2008 winter season. This study aims
to contribute to global surveillance on antiviral resistance
and to risk assessment of drug use with continuous liber-
ation of national data. Its main objective is to evaluate
inﬂuenza virus susceptibility to oseltamivir and amantadine
during 2004/2005—2007/2008, in Portugal.
Methods: Susceptibility to oseltamivir was eval-
uated by ﬂuorescence assay in 233 strains from
2004/2005—2007/2008. NA and HA1 gene sequencing
was performed in statistical outliers and in 30% of sus-
ceptible strains, identiﬁed by ﬂuorescence. Resistance to
amantadine was evaluated by pyrosequencing in 128 strains
from 2004/2005—2006/2007.
Results: All 89 A(H3N2) and 94 B inﬂuenza strains
tested shown to be oseltamivir-susceptible. Of the 50
A(H1N1) strains tested, 3 of the 14 from 2007/2008
were drug-resistant by exhibiting ﬂuorescence-IC50 values
approximately 400 times higher than the median value and
mutation H274Y in NA sequence. Susceptibility to aman-
tadine was detected in all 23 A(H1N1) strains tested.
Resistance was found, by identiﬁcation of mutation S31N in
M2 sequence, in 24 of the 105 A(H3N2) strains tested: in the
single strain from 2005/2006 and in 23 of the 35 strains from
2006/2007.
Discussion: The origin of oseltamivir-resistant A(H1N1)
strains in Portugal (2007/2008), and concurrently in other
European countries, remains unclear. Their persistence
through inﬂuenza seasons and their effect in viral evolution
could become clearer with subsequent and continuous data
analysis. Conversely, emergence of amantadine resistance
in Portugal, identiﬁed in 2005/2006 and persistent through
2006/2007, probably derived from global spread of A(H3N2)
virus bearing mutation S31N. These preliminary ﬁndings can
presently contribute to monitor international dispersion of
resistant viruses. Continuous and timely input of national
data onto global surveillance constitutes the basis for risk
assessment on antiviral drug use.
doi:10.1016/j.ijid.2008.05.815
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Management of Dengue in Patients on Antithrombotic
Therapy
H.C. Tan ∗, N. Chlebicka, B.H. Tan, H.N. Leong
Singapore General Hospital, Singapore, Singapore
Background: Recently, there has been a marked resur-
gence of Dengue Fever (DF) in Singapore. More adults with
chronic diseases including patients on antithrombotic ther-
